C.A. Uyl-de Groot

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff et al. · Journal of Clinical Oncology · 2003 · 168 citations

Medicine, Geriatric Medicine, Oncology +13

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

Edo Vellenga, C.A. Uyl-de Groot, Ronald de Wit et al. · Journal of Clinical Oncology · 1996 · 96 citations · Full text

Medicine, Immunology, Oncology +14

Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).

C.A. Uyl-de Groot, Anton Hagenbeek, LF Verdonck et al. · PubMed · 1995 · 58 citations

Medicine, Oncology, Pharmacoeconomics +8

Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study

Hedwig M. Blommestein, S. Verelst, Peter C. Huijgens et al. · Annals of Hematology · 2012 · 53 citations

Medicine, Hematology, Pharmacoeconomics +12

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

J Gaultney, M Franken, Siok Swan Tan et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 50 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17